Streetbeat News

Revenues

CWCO

Consolidated Water Co (NASDAQ:CWCO) reported Q1 2024 earnings per share (EPS) of $0.43, beating the analyst estimate of $0.33 by 30.3%. Sales were $39.689 million, surpassing the $38.200 million estimate. Both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:07 pm

CSCO

Cisco has provided its Q4 and FY24 financial guidance. For Q4, the company expects adjusted EPS between $0.84 and $0.86, slightly above the consensus estimate of $0.85. Revenue is projected to be between $13.4 billion and $13.6 billion, also above the estimate of $13.23 billion. For FY24, Cisco anticipates adjusted EPS of $3.69 to $3.71, compared to the estimate of $3.67, and revenue of $53.6 billion to $53.8 billion, exceeding the estimate of $53.14 billion.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:07 pm

NURO

NeuroMetrix (NASDAQ:NURO) reported a Q1 EPS of $(1.67), a slight increase in losses from $(1.64) YoY, and sales of $1.09M, a 36.64% decrease from $1.73M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:07 pm

CSCO

Cisco Systems (NASDAQ:CSCO) reported Q3 2024 adjusted EPS of $0.88, beating the estimate of $0.82. Sales were $12.7 billion, surpassing the $12.531 billion estimate but reflecting a 12.84% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:05 pm

YTEN

Yield10 Bioscience (NASDAQ:YTEN) reported Q1 2024 adjusted EPS of $(4.77), missing the $(2.64) estimate by 80.68%. Sales were $300K, missing the $1.88M estimate by 84%. Despite the misses, sales increased 400% from $60K last year.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:04 pm

VBIV

VBI Vaccines (NASDAQ:VBIV) reported a significant improvement in its Q1 financial results, with EPS losses narrowing to $(0.73) from $(3.22) YoY and sales increasing to $1.21M from $485K YoY.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:04 pm

NURO

NeuroMetrix reported Q1 revenue of $1.093 million, a decrease from $1.724 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:03 pm

GLPG

Galapagos NV (NASDAQ: GLPG) has entered into a strategic collaboration with Blood Centers of America (BCA) to expand its decentralized CAR-T manufacturing network in the U.S. This partnership will leverage BCA's extensive network of blood centers to enhance the manufacturing and distribution of Galapagos' CAR-T therapies, improving patient access and supporting upcoming pivotal trials.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 8:03 pm

AXP

American Express (NYSE:AXP) has outperformed the market over the past 5 years with an average annual return of 14.94%, resulting in a $100 investment growing to $201.77. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

May 15, 2024 | 8:00 pm

RRX

Regal Rexnord (NYSE:RRX) has outperformed the market over the past 20 years with an average annual return of 11.08%, resulting in a $1000 investment growing to $8,290.47. The company currently has a market capitalization of $10.80 billion.

Portfolio Pulse from Benzinga Insights

May 15, 2024 | 8:00 pm